QIAGEN Reports Results for Fourth Quarter and Full-Year 2015

VENLO, The Netherlands, February 2, 2016 /PRNewswire/ — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced results of operations for the fourth quarter and full-year 2015, delivering higher adjusted net sales and earnings at constant exchange rates (CER) while setting goals for accelerating growth and further innovation in 2016. “QIAGEN made significant progress in... Read more

Fluorescent light helps surgeons target brain tumors

At Leica we are proud that our products provide surgeons with enhanced visualization so they can preserve or improve quality of life for their patients. A recent broadcast by the US network Fox News describes how a substance called 5-aminolevulinic acid (5-ALA), used with FL400 fluorescence from Leica, supported a neurosurgeon during a successful brain... Read more

Neogen develops superior chromogenic media for Salmonella

CONTACT: Joanne McPeake, Neogen Europe Ltd., +44 (0) 1292 525 600 AYR, Scotland, 18 January, 2017 — Neogen’s Lab M has developed a unique chromogenic media that offers a superior ability to simultaneously detect numerous strains of Salmonella of concern to the food and animal feed industries, while inhibiting or minimizing other organisms. This new... Read more

Roka Bioscience Announces Transition of CEO Role from Paul Thomas to Mary Duseau

WARREN, N.J., Jan. 17, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens today announced the appointment of Mary Duseau as President and CEO.  Ms. Duseau succeeds Paul Thomas, the Company’s President and CEO since 2009, who will assume the... Read more

Takara Bio USA Holdings, Inc. completes acquisition of Rubicon Genomics, Inc.

Takara Bio USA Holdings, Inc. completes acquisition of Rubicon Genomics, Inc. Mountain View, CA—January 18, 2017—Takara Bio USA Holdings, Inc. (“TBUSH”) announced that it has completed the acquisition of Rubicon Genomics, Inc. (“Rubicon”), Rubicon has become a wholly-owned subsidiary of TBUSH as of January 17, 2017 (US local time). Under the merger agreement executed with Rubicon,... Read more

Congenica Expands in North America with Strategic Appointment

Congenica Expands in North America with Strategic Appointment Shikha O’Brien, Chief Business Officer Genomics Analysis Leader Appoints Dr Shikha O’Brien as Chief Business Officer 16th January 2017, Cambridge UK Congenica, a world leading developer of genome analysis and interpretation technologies, expands its operations in the US with the announcement that it has recruited Dr Shikha... Read more

Nikon Instruments Inc. Celebrates 100 Years of Imaging

MELVILLE, N.Y., Jan. 17, 2017 (GLOBE NEWSWIRE) — As Nikon celebrates its centennial in 2017, Nikon Instruments Inc., innovator of advanced optical instruments, looks back on 100 years of scientific discovery and advancements under the microscope. Nikon invites the public to explore their journey through light firsthand in the 100th Anniversary microsite launched this week... Read more

Smiths Group welcomes European Commission clearance for acquisition of Morpho Detection

19 Jan 2017 Smiths Group plc (“Smiths Group”) welcomes the European Commission’s clearance of the proposed acquisition of Morpho Detection. In order to secure approval in Phase I of the EU merger review process, Smiths Group proposed the divestment of Morpho Detection’s explosive trace detection (“Trace”) business. This divestment is conditional on the successful closing... Read more